Erythromycin Ethylsuccinate for Oral Suspension is indicated for the treatment of susceptible infections including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires’ disease, pertussis, and listeriosis. Erythromycin Ethylsuccinate is an oral macrolide that acts by inhibition of protein synthesis through binding 50S ribosomal subunits of susceptible organisms. It does not affect nucleic acid synthesis.
Erythromycin Ethylsuccinate for Oral Suspension is available as a 200mg/5mL strength.
For more information call (800) 434-1121 or visit ANIpharmaceuticals.com.